Table 2 Geometric means and 95% C.I. of antibody titers (IU/mL) in the maternal specimens analyzeda.
IgG geometric mean (95% C.I.) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
T0 | T1 | T2 | T3 | T4 | |||||||
Serum | Anti-S | 22.37 | (19.46–25.71) | 160.6 | (119.00–216.80) | 581.9 | (486.50–696) | 507.2 | (394.80–651.70) | 357 | (284.50–447.90) |
Anti-RBD | 42.28 | (41.49–43.08) | 338.7 | (253.50–452.40) | 1089 | (928.80–1278) | 908.8 | (752.20–1098) | 703.3 | (544.60–908.20) | |
Saliva | Anti S | 0.26 | (0.26–0.27) | 0.33 | (0.29–0.38) | 0.5 | (0.40–0.62) | 0.37 | (0.33–0.41) | 0.32 | (0.31–0.33) |
Anti-RBD | 1.12 | (1.12–1.12) | 1.10 | (1.03–1.17) | 1.99 | (1.53–2.57) | 1.32 | (1.14–1.53) | 1.13 | (1.08–1.18) | |
Breast milk | Anti-S | 2.04 | (2.03–2.05) | 2.17 | (2.10–2.25) | 3.78 | (3.11–4.60) | 2.97 | (2.47–3.56) | 2.52 | (2.26–2.82) |
Anti-RBD | 4.06 | (4.03–4.09) | 4.42 | (4.10–4.77) | 9.19 | (6.83–12.40) | 6.21 | (5.12–7.53) | 5.02 | (4.41–5.71) | |
IgA geometric mean (95% C.I.) | |||||||||||
T0 | T1 | T2 | T3 | T4 | |||||||
Serum | Aanti-S | 45.2 | (37.89–53.93) | 119.1 | (73.81–192.1) | 87 | (66.36–114.1) | 81.09 | (61.46–107) | 69.54 | (53.25–90.81) |
Anti-RBD | 54.73 | (34.22–87.52) | 84.75 | (39.22–183.1) | 160.3 | (94.25–272.7) | 61.13 | (23.89–156.4) | 35.04 | (14.57–84.31) | |
Saliva | Anti S | 1.14 | (0.973–1.33) | 2.049 | (1.40–3.01) | 1.75 | (1.47–2.08) | 1.659 | (1.27–2.17) | 1.569 | (1.28–1.92) |
Anti-RBD | 0.23 | (0.054–0.92) | 1.69 | (0.76–3.73) | 1.43 | (0.65–3.17) | 0.92 | (0.35–2.41) | 0.91 | (0.36–2.28) | |
Breast milk | Anti-S | 8.54 | (6.56–11.19) | 13.37 | (8.68–20.59) | 12.88 | (7.72–21.49) | 11.95 | (7.06–20.22) | 12.87 | (7.62–21.74) |
Anti-RBD | 11.13 | (7.97–15.54) | 20.58 | (14.76–28.68) | 18.12 | (12.78–25.68) | 15.75 | (10.54–23.53) | 16.67 | (11.25–24.7) | |